KM Sullivan

4.4k total citations
50 papers, 3.4k citations indexed

About

KM Sullivan is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, KM Sullivan has authored 50 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 12 papers in Immunology and 10 papers in Oncology. Recurrent topics in KM Sullivan's work include Hematopoietic Stem Cell Transplantation (42 papers), Acute Myeloid Leukemia Research (8 papers) and T-cell and B-cell Immunology (8 papers). KM Sullivan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (42 papers), Acute Myeloid Leukemia Research (8 papers) and T-cell and B-cell Immunology (8 papers). KM Sullivan collaborates with scholars based in United States, South Africa and Australia. KM Sullivan's co-authors include Rainer Storb, FR Appelbaum, H. Joachim Deeg, CD Buckner, RP Witherspoon, JE Sanders, Claudio Anasetti, KC Doney, RP Witherspoon and A Fefer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Pharmacology.

In The Last Decade

KM Sullivan

50 papers receiving 3.2k citations

Peers

Countries citing papers authored by KM Sullivan

Since Specialization

Citations

This map shows the geographic impact of KM Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KM Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KM Sullivan more than expected).

Fields of papers citing papers by KM Sullivan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by KM Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KM Sullivan. The network helps show where KM Sullivan may publish in the future.

Co-authorship network of co-authors of KM Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of KM Sullivan. A scholar is included among the top collaborators of KM Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with KM Sullivan. KM Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical characterization of WAY‐211612: a dual 5‐HT uptake inhibitor and 5‐HT_1Areceptor antagonist and potential novel antidepressant 2009 ·British Journal of Pharmacology ·(unknown), Qian Lin, Brian J. Platt, Jessica E. Malberg, Geoffrey Hornby, KM Sullivan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ronald L. Magolda, (unknown), (unknown), Sharon Rosenzweig‐Lipson, (unknown)	8
2	Preventing Opportunistic Infections After Hematopoietic Stem Cell Transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and Beyond 2001 ·Hematology ·KM Sullivan, Clare A. Dykewicz, David L. Longworth, Michael Boeckh, Lindsey R. Baden, R H Rubin, K. A. Sepkowitz	107
3	Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease. 1997 ·PubMed ·(unknown), (unknown), (unknown), J. Lee Nelson, Jordan Gauthier, D.E. Furst, KM Sullivan	14
4	RELATIONSHIP OF SERUM CYTOKINES (TNF-ALPHA, IL-1-BETA, IFN-GAMMA AND INFLAMMATION MARKERS (NEOPTERIN, BETA-2-MICROGLOBULIN, C-REACTIVE PROTEIN) TO TRANSPLANT-RELATED COMPLICATIONS AND IMMUNOGLOBULIN PROPHYLAXIS FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION 1994 ·Ghent University Academic Bibliography (Ghent University) ·KM Sullivan, Fritz Offner, Manfred Herold, Masaru Mori, Christian G. Huber, D Niederwieser, FR Appelbaum, R Storb	1
5	Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. 1992 ·Journal of Clinical Oncology ·R. A. Clift, CD Buckner, F R Appelbaum, Gary Schoch, Finn Bo Petersen, Jack W. Singer, Jan‐Stephan Sanders, KM Sullivan, Rainer Storb	91
6	Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone [letter; comment] 1992 ·Blood ·RP Witherspoon, (unknown), (unknown), (unknown), KM Sullivan	1
7	Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone 1992 ·Blood ·K Doney, M. S. Pepe, Rainer Storb, EM Bryant, Claudio Anasetti, FR Appelbaum, CD Buckner, JE Sanders, Jack W. Singer, KM Sullivan	53
8	Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation 1990 ·Blood ·TP Jr Loughran, KM Sullivan, Thomas Hellman Morton, C Beckham, Mark Schubert, Robert P. Witherspoon, George Sale, Jan‐Stephan Sanders, Lloyd D. Fisher, Howard M. Shulman	50
9	High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. 1988 ·Journal of Clinical Oncology ·Stanley R. Riddell, F R Appelbaum, CD Buckner, Patricia Stewart, R. A. Clift, JE Sanders, Rainer Storb, KM Sullivan, E. Donnall Thomas	49
10	Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia 1988 ·Blood ·JE Sanders, CD Buckner, Thomas Ed, (unknown), KM Sullivan, (unknown), R Storb	64
11	Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation 1988 ·Blood ·KM Sullivan, RP Witherspoon, Rainer Storb, Paul L. Weiden, Nancy Flournoy, S Dahlberg, H. Joachim Deeg, JE Sanders, KC Doney, FR Appelbaum	273
12	Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin 1987 ·Blood ·Rainer Storb, PL Weiden, KM Sullivan, FR Appelbaum, P Beatty, CD Buckner, Clift Ra, KC Doney, John A. Hansen, PJ Martin	86
13	Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin 1987 ·Blood ·Rainer Storb, PL Weiden, KM Sullivan, FR Appelbaum, P Beatty, CD Buckner, Clift Ra, KC Doney, John A. Hansen, PJ Martin	8
14	Bone marrow transplantation in patients aged 45 years and older 1986 ·Blood ·Klingemann Hg, Rainer Storb, A Fefer, H. Joachim Deeg, FR Appelbaum, CD Buckner, MA Cheever, (unknown), PS Stewart, KM Sullivan	118
15	Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors 1986 ·Blood ·H. Joachim Deeg, (unknown), Rainer Storb, (unknown), FR Appelbaum, RP Witherspoon, KM Sullivan, (unknown), Jan‐Stephan Sanders, (unknown)	8
16	Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation 1986 ·Blood ·KM Sullivan, H. Joachim Deeg, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
17	Marrow harvesting from normal donors 1984 ·Blood ·CD Buckner, Clift Ra, JE Sanders, (unknown), Jack W. Singer, KC Doney, KM Sullivan, RP Witherspoon, H. Joachim Deeg, FR Appelbaum	8
18	Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients 1983 ·Blood ·KM Sullivan, Neiman Pe, ME Kadin, (unknown), Vernon T. Farewell, (unknown), (unknown), FR Appelbaum, Thomas Ed	1
19	Low serum thymic hormone levels in patients with chronic graft-versus- host disease 1982 ·Blood ·K Atkinson, G S Incefy, Rainer Storb, KM Sullivan, Toshio Iwata, Mireille Dardenne, HD Ochs, Good Ra, Thomas Ed	30
20	Low serum thymic hormone levels in patients with chronic graft-versus- host disease 1982 ·Blood ·(unknown), G S Incefy, (unknown), KM Sullivan, (unknown), (unknown), HD Ochs, Good Ra, Thomas Ed	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact